Market Research Logo

Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2016

Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2016

Summary


Global Markets Direct’s, ‘Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2016’, provides an overview of the Kyowa Hakko Kirin Co., Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Kyowa Hakko Kirin Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Kyowa Hakko Kirin Co., Ltd.
  • The report provides overview of Kyowa Hakko Kirin Co., Ltd. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Kyowa Hakko Kirin Co., Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Kyowa Hakko Kirin Co., Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Kyowa Hakko Kirin Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Kyowa Hakko Kirin Co., Ltd.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Kyowa Hakko Kirin Co., Ltd.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Kyowa Hakko Kirin Co., Ltd. Snapshot
Kyowa Hakko Kirin Co., Ltd. Overview
Key Information
Key Facts
Kyowa Hakko Kirin Co., Ltd. - Research and Development Overview
Key Therapeutic Areas
Kyowa Hakko Kirin Co., Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products Glance
Kyowa Hakko Kirin Co., Ltd. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Kyowa Hakko Kirin Co., Ltd. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Kyowa Hakko Kirin Co., Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Kyowa Hakko Kirin Co., Ltd. - Drug Profiles
brodalumab
Product Description
Mechanism of Action
R&D Progress
darbepoetin alfa
Product Description
Mechanism of Action
R&D Progress
granisetron ER
Product Description
Mechanism of Action
R&D Progress
romiplostim
Product Description
Mechanism of Action
R&D Progress
tivozanib hydrochloride
Product Description
Mechanism of Action
R&D Progress
benralizumab
Product Description
Mechanism of Action
R&D Progress
burosumab
Product Description
Mechanism of Action
R&D Progress
istradefylline
Product Description
Mechanism of Action
R&D Progress
mogamulizumab
Product Description
Mechanism of Action
R&D Progress
MT-4580
Product Description
Mechanism of Action
R&D Progress
tivantinib
Product Description
Mechanism of Action
R&D Progress
bardoxolone methyl
Product Description
Mechanism of Action
R&D Progress
bleselumab
Product Description
Mechanism of Action
R&D Progress
KHK-4083
Product Description
Mechanism of Action
R&D Progress
BIW-8962
Product Description
Mechanism of Action
R&D Progress
antithrombin III (human)
Product Description
Mechanism of Action
R&D Progress
entinostat
Product Description
Mechanism of Action
R&D Progress
KHK-2823
Product Description
Mechanism of Action
R&D Progress
KHK-2898
Product Description
Mechanism of Action
R&D Progress
KHK-6640
Product Description
Mechanism of Action
R&D Progress
CHKM-4927
Product Description
Mechanism of Action
R&D Progress
K-685
Product Description
Mechanism of Action
R&D Progress
K-756
Product Description
Mechanism of Action
R&D Progress
KHK-KRAS
Product Description
Mechanism of Action
R&D Progress
KHK-XXX
Product Description
Mechanism of Action
R&D Progress
KM-2812
Product Description
Mechanism of Action
R&D Progress
Pr-1E11
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit ASK1 for Amyotropic Lateral Sclerosis
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Mitotic Kinesin Eg5 for Ovarian Cancer
Product Description
Mechanism of Action
R&D Progress
Z-3G1
Product Description
Mechanism of Action
R&D Progress
K-777
Product Description
Mechanism of Action
R&D Progress
Small Molecules Targeting Protein-Protein Interactions for Undisclosed Indication
Product Description
Mechanism of Action
R&D Progress
Kyowa Hakko Kirin Co., Ltd. - Pipeline Analysis
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Target
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Route of Administration
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Molecule Type
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Mechanism of Action
Kyowa Hakko Kirin Co., Ltd. - Recent Pipeline Updates
Kyowa Hakko Kirin Co., Ltd. - Dormant Projects
Kyowa Hakko Kirin Co., Ltd. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
AGS-004
darbepoetin alfa
KHK-2866
KHK-6188
KRN-330
KRX-0601
KW-2449
KW-2450
KW-2478
KW-7158
litronesib
mogamulizumab
pibrozelesin hydrobromide
rocapuldencel-t
SAR-252067
tivantinib
tivozanib hydrochloride
Kyowa Hakko Kirin Co., Ltd. - Company Statement
Kyowa Hakko Kirin Co., Ltd. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Kyowa Hakko Kirin Co., Ltd., Key Information
Kyowa Hakko Kirin Co., Ltd., Key Facts
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Indication, 2016
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Stage of Development, 2016
Kyowa Hakko Kirin Co., Ltd. - Monotherapy Products in Pipeline, 2016
Kyowa Hakko Kirin Co., Ltd. - Partnered Products in Pipeline, 2016
Kyowa Hakko Kirin Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2016
Kyowa Hakko Kirin Co., Ltd. - Out-Licensed Products in Pipeline, 2016
Kyowa Hakko Kirin Co., Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2016
Kyowa Hakko Kirin Co., Ltd. - Pre-Registration, 2016
Kyowa Hakko Kirin Co., Ltd. - Phase III, 2016
Kyowa Hakko Kirin Co., Ltd. - Phase II, 2016
Kyowa Hakko Kirin Co., Ltd. - Phase I, 2016
Kyowa Hakko Kirin Co., Ltd. - Preclinical, 2016
Kyowa Hakko Kirin Co., Ltd. - Discovery, 2016
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Target, 2016
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Route of Administration, 2016
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Molecule Type, 2016
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Mechanism of Action, 2016
Kyowa Hakko Kirin Co., Ltd. - Recent Pipeline Updates, 2016
Kyowa Hakko Kirin Co., Ltd. - Dormant Developmental Projects,2016
Kyowa Hakko Kirin Co., Ltd. - Discontinued Pipeline Products, 2016
Kyowa Hakko Kirin Co., Ltd., Other Locations
Kyowa Hakko Kirin Co., Ltd., Subsidiaries
List of Figures
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Top 10 Indication, 2016
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Stage of Development, 2016
Kyowa Hakko Kirin Co., Ltd. - Monotherapy Products in Pipeline, 2016
Kyowa Hakko Kirin Co., Ltd. - Partnered Products in Pipeline, 2016
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Top 10 Target, 2016
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Route of Administration, 2016
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Molecule Type, 2016
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report